Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
7.28 USD
-0.27%
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
The Relative Value of one
LUNG
stock under the Base Case scenario is
10.84
USD.
Compared to the current market price of 7.28 USD,
Pulmonx Corp
is
Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LUNG
Relative Value
Base Case
10.84
USD
Undervaluation 33%
Valuation Multiples
Multiples Across Competitors
LUNG Competitors Multiples
Pulmonx Corp Competitors
Pulmonx Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pulmonx Corp
NASDAQ:LUNG
|
280.4m USD | 4.1 | -4.6 | -4.3 | -4.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.4T JPY | 8.6 | 38.5 | 23.4 | 28.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.5B CHF | 4.1 | 40 | 17.8 | 36.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
194.1B DKK | 7.8 | 39.9 | 26.2 | 30.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 6 | 52.1 | 27.8 | 33.8 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
17.7B USD | 4.8 | 60.7 | 22.3 | 37.8 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.3T KRW | 333.3 | -75.6 | -123.3 | -113.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.1B CNY | 14 | 33.3 | 29 | 29 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 50.7 | 46.8 | 50.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -48 | 12.2 | 26.3 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 1.3 | -20 | 15.8 | 44.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
